Excelsior Medical Co (TPE:4104) Cyclically Adjusted Revenue per Share: NT$ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4104 Excelsior Medical Co Ltd TPE:4104
86 GF Score
Price NT$72.70
GF Value NT$86.67
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Excelsior Medical Co Cyclically Adjusted Revenue per Share?

Excelsior Medical Co TPE:4104 +0.69% 86 Cyclically Adjusted Revenue per Share is NT$ as of Jun. 2026. GuruFocus rates TPE:4104 with a GF Score™ of 86/100 and a GF Value™ of NT$86.67 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Excelsior Medical Co's adjusted revenue per share for the three months ended in Jun. 2026 was NT$12.812. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$ for the trailing ten years ended in Jun. 2026.

During the past 12 months, Excelsior Medical Co's average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Excelsior Medical Co was 3.70% per year. The lowest was 1.90% per year. And the median was 2.50% per year.

As of today (2026-09-20), Excelsior Medical Co's current stock price is NT$72.70. Excelsior Medical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was NT$. Excelsior Medical Co's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Excelsior Medical Co was 1.80. The lowest was 0.90. And the median was 1.38.


Excelsior Medical Co  (TPE:4104) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Excelsior Medical Co was 1.80. The lowest was 0.90. And the median was 1.38.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Excelsior Medical Co Cyclically Adjusted Revenue per Share Related Terms


Excelsior Medical Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Excelsior Medical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Excelsior Medical Co Cyclically Adjusted Revenue per Share Chart

Excelsior Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Excelsior Medical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TPE:4104 vs MCK, COR, CAH: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Excelsior Medical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Excelsior Medical Co Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Excelsior Medical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Excelsior Medical Co's Cyclically Adjusted PS Ratio falls into.


TPE:4104
86GF Score
Excelsior Medical Co Ltd TPE:4104
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Excelsior Medical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Excelsior Medical Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=12.812/333.9520*333.9520
=12.812

Current CPI (Jun. 2026) = 333.9520.

Excelsior Medical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 9.624 241.428 13.312
201612 9.978 241.432 13.802
201703 9.241 243.801 12.658
201706 9.436 244.955 12.864
201709 9.475 246.819 12.820
201712 9.828 246.524 13.313
201803 9.641 249.554 12.902
201806 9.749 251.989 12.920
201809 9.904 252.439 13.102
201812 10.103 251.233 13.429
201903 9.911 254.202 13.020
201906 9.627 256.143 12.551
201909 10.002 256.759 13.009
201912 10.660 256.974 13.853
202003 10.033 258.115 12.981
202006 9.150 257.797 11.853
202009 9.661 260.280 12.396
202012 9.500 260.474 12.180
202103 9.294 264.877 11.718
202106 9.040 271.696 11.111
202109 8.999 274.310 10.956
202112 10.164 278.802 12.175
202203 9.745 287.504 11.319
202206 9.579 296.311 10.796
202209 10.517 296.808 11.833
202212 11.173 296.797 12.572
202303 11.504 301.836 12.728
202306 11.578 305.109 12.673
202309 11.567 307.789 12.550
202312 12.456 306.746 13.561
202403 11.678 312.332 12.486
202406 12.375 314.175 13.154
202409 11.786 315.301 12.483
202412 12.959 315.605 13.712
202503 12.290 319.799 12.834
202506 12.420 322.561 12.859
202509 12.521 324.800 12.874
202512 12.979 324.054 13.375
202603 12.734 330.213 12.878
202606 12.812 333.952 12.812

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$ mean?
Excelsior Medical Co (TPE:4104) has a Cyclically Adjusted Revenue per Share of NT$ as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Excelsior Medical Co and its competitors.
Is Excelsior Medical Co's Cyclically Adjusted Revenue per Share too high?
Excelsior Medical Co's current Cyclically Adjusted Revenue per Share is NT$. Overall, Excelsior Medical Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's Cyclically Adjusted Revenue per Share compare to MCK and COR?
Excelsior Medical Co's Cyclically Adjusted Revenue per Share of NT$ can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Excelsior Medical Co and its competitors. Excelsior Medical Co's current Cyclically Adjusted Revenue per Share is NT$. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$86.67, compared to a current price of NT$72.70 — trading 16.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$. Excelsior Medical Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current Cyclically Adjusted Revenue per Share is NT$ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?

Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued. The current stock price of NT$72.70 is trading 16.1% below its estimated GF Value™ of NT$86.67. GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.

Key valuation signals for TPE:4104:

  • Cyclically Adjusted Revenue per Share: NT$
  • GF Value™: NT$86.67 vs. price of NT$72.70 (16.1% below fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Excelsior Medical Co Business Description

Address Zhongzheng Road, No. 880, 17th Floor, Zhonghe District, New Taipei City, TWN, 235
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
86GF Score

Get the complete analysis for TPE:4104

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$72.70
Price
NT$86.67
GF Value